Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Precision BioSciences Gets Second ACP For Cellectis Core Technology
The PTO, for the second time, has denied all claims under consideration as lacking novelty and/or as obvious in view of a variety of references, including many that
The PTO, for the second time, has denied all claims under consideration as lacking novelty and/or as obvious in view of a variety of references, including many that
Isis claimed that ISIS-SOD1Rx is an anti-sense drug designed to restrict the production of SOD1. The ALS Association and the Muscular Dystrophy Association are providing funding for the
Archexin is a potent inhibitor of Akt protein kinase in the treatment of cancer. Akt regulates signal processes of cell proliferation and survival, angiogenesis, and drug resistance in
Taro said that its fluorouracil cream is a prescription pharmaceutical product used for topical treatment of multiple actinic or solar keratoses and superficial basal cell carcinomas, and is
The studies were presented at the American Society of Clinical Oncology’s (ASCO) Genitourinary (GU) Cancers Symposium in San Francisco. In the two studies, PCA3 was used to test
MitoTarget consortium said that the multilingual web-based resource aims to be the first point of call for all of those affected by ALS. The website contains detailed information
Fenwal said that its InterSol solution has been approved by the FDA in December 2009 under a new drug application. It is the platelet additive solution available in
The data were presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), held March 5-7, 2010 in San Francisco, CA. TAK-700, discovered by Takeda,
The MicroPhage’s instrument-free, rapid tests are based on its patented Bacteriophage Amplification platform technology. The company has also begun OUS commercial shipments of the test. MicroPhage’s initial commercial
The Pancreas, Biliary and Liver Surgery Center is under the leadership of Dr Michael Wayne, Dr Franklin Kassim and Dr Avram Cooperman. Under the terms of the agreement,